This editorial discusses the potential role of AI-enabled ECGs in managing patients with cryptogenic stroke, a population where empiric anticoagulation currently lacks proven benefit and carries bleeding risks.
Approximately 20% of all ischemic strokes are cryptogenic—they have an uncertain cause despite thorough diagnostic evaluation.1 Many such patients undergo long-term cardiac monitoring for detection of atrial fibrillation (AF), but in the absence of clearly documented AF, there is controversy regarding the best approach to secondary prevention.2 While anticoagulation may seem reasonable for some patients, empiric anticoagulation has not been shown to prevent recurrent events and may not outweigh the risk of bleeding in patients with embolic stroke of unknown source (ie, cryptogenic strokes with embolic pattern on brain imaging but no documented embolic source).
No takes yet. Share an insight, caveat, or question.
Kashou et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: